Neovacs S.A. (EPA:ALNEV)
France · Delayed Price · Currency is EUR 0.0002
0.00 (0.00%)
May 13, 2026, 5:38 PM CET
Neovacs Market Cap
Neovacs has a market cap or net worth of €95 as of May 13, 2026. Its market cap has decreased by -99.82% in one year.
Market Cap
95.00
Enterprise Value
132.25K
Revenue
199.27K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.00
Market Cap Chart
Since November 5, 2024, Neovacs's market cap has decreased from 296.00K to 95.00, a decrease of -99.97%. That is a compound annual growth rate of -99.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 95.00 | -97.71% |
| Dec 31, 2025 | 4.15K | -97.26% |
| Dec 31, 2024 | 151.14K | -48.94% |
| Nov 5, 2024 | 296.00K | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aelis Farma | 17.51M |
| Aton | 15.40M |
| Poxel | 13.89M |
| Advicenne | 13.32M |
| NFL Biosciences | 12.19M |
| Oncodesign Precision Medicine Société anonyme | 8.28M |
| Plant Advanced Technologies | 7.57M |
| TME Pharma | 7.41M |